Data Quality: Drug Discovery AI’s Indispensable Foundation
-
By
-
Andrea Jacobs
-
August 25, 2026
-
6 min
By
Andrea Jacobs
August 25, 2026
The phase 2/3 ENERGY trial evaluated durable hemoglobin response with nipocalimab vs placebo in adults with warm autoimmune hemolytic anemia.
August 25, 2026
A flexible contact lens platform could bring continuous ocular oximetry closer to the clinic, says study
August 25, 2026